Octreotide
Photos »
/ 
Related News »
SAN DIEGO, CA--(Marketwire - May 21, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,133,863 providing broad protection for pharmaceutical composition of octreotide. The highly stable octreotide formulations ...
May 21, 2012 at 07:54 | Source: Market Wire
To investigate the therapeutic effects of fluorouracil (5-Fu) and octreotide (Oct) continuous regional arterial infusion (CRAI,) alone or in combination, was administered in a canine model of severe acute pancreatitis (SAP). Materials and Methods The ...
May 25, 2012 at 11:46 | Source: Elites TV
Lutetium octreotide therapy is another upcoming treatment option for thyroid cancer, currently available at AIIMS. It shall not be out of place to mention here that Lu177- Octreotide therapy is not available even in USA. Currently, only few countries in ...
May 24, 2012 at 10:35 | Source: pharmabiz.com
The randomized, double-blind phase III study, PASPORT-ACROMEGALY (PASireotide clinical trial PORTfolio - ACROMEGALY), compared the efficacy and safety of pasireotide LAR with Sandostatin LAR (octreotide/IM injection) in 358 treatment naïve ...
May 9, 2012 at 16:44 | Source: Yahoo Finance
504.2.3 Sandostatin LAR (octreotide acetate) 514.3 Key Takeaway 515 Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment 525.1 Overview 525.2 Strategic Pipeline Assessment 525.3 Analysis by Phase of Development 535.3.1 Neuroendocrine ...
May 15, 2012 at 12:41 | Source: Yahoo Finance